跳至主要内容
临床试验/CTRI/2025/02/080426
CTRI/2025/02/080426招募中2/3 期

Comparative clinical study on efficacy of Sankhapushpi and Jatamansi churna in Chittodvega with special reference to Generalized Anxiety Disorder.

Dr Jimima Aktar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年2月22日最近更新:

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
To compare the efficacy of Sankhapushpi and Jatamansi churna in Generalized anxiety disorder(Chittodvega).

研究概览

简要总结

This is a randomized, parallel comparative clinical study on efficacy of Sankhapushpi and Jatamansi churna for the management of Generalized anxiety disorder.Total 60 number of patients divided in two groups and each group will be given 3 gms of powder twice daily orally and both drugs efficacy will be compared  . Assessment will be done in every 15,30,45th day based on symptoms in anxiety rating scale.This study conducted as a mandatory Post graduation thesis work.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patients of age group 18 to 50yrs both male and female having anxiety of minimum 6 months duration fulfilling the diagnostic criteria DSM4/DSM5 or atleast 14 on the Hamilton anxiety rating scale.

排除标准

  • 1.Patient below 18 yrs and above 50 yrs.
  • 2.Patient with major Psychiatric illness like Schizophrenia, Depressive psychosis, Epilepsy etc.
  • 3.Patient like Lactating mothers, Pregnant women, medical condition like Hypothyroidism etc.
  • 4.Patients with acute illness like CVA,CCF,MI etc.

结局指标

主要结局

To compare the efficacy of Sankhapushpi and Jatamansi churna in Generalized anxiety disorder(Chittodvega).

时间窗: 45 days

次要结局

  • Assessment will be done according to improvement in the anxiety rating scale.(15,30,45 days.)

研究者

发起方
Dr Jimima Aktar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Jimima Aktar

Govt Ayurvedic college and Hospital Ghy 14

研究点 (1)

Loading locations...

相似试验